https://celldex.com/publications/ 2026-10-13T12:22:10+00:00 https://celldex.com/publications/383/ 2025-06-04T02:44:11+00:00 https://celldex.com/publications/barzolvolimab-improves-urticaria-control-and-quality-of-life-in-patients-with-chronic-spontaneous-urticaria-52-week-data/ 2025-06-04T03:02:03+00:00 https://celldex.com/publications/positive-efficacy-and-favorable-safety-of-barzolvolimab-in-chronic-inducible-urticaria-phase-2-trial-results/ 2025-06-04T03:03:21+00:00 https://celldex.com/publications/barzolvolimab-shows-profound-efficacy-and-favorable-safety-over-52-weeks-in-patients-with-chronic-spontaneous-urticaria/ 2025-06-04T03:04:18+00:00 https://celldex.com/publications/barzolvolimab-significantly-decreases-chronic-spontaneous-urticaria-disease-activity-and-is-well-tolerated-top-line-results-from-a-phase-2-trial/ 2025-06-04T03:05:45+00:00 https://celldex.com/publications/barzolvolimab-significantly-improves-angioedema-in-patients-with-chronic-spontaneous-urticaria-csu-results-from-a-phase-2-trial/ 2025-06-04T03:06:01+00:00 https://celldex.com/publications/barzolvolimab-demonstrates-safety-and-clinically-meaningful-activity-in-moderate-severe-prurigo-nodularis/ 2025-06-04T03:07:03+00:00 https://celldex.com/publications/safety-and-clinical-activity-of-multiple-doses-of-barzolvolimab-an-anti-kit-antibody-in-patients-with-chronic-spontaneous-urticaria/ 2025-06-04T16:44:59+00:00 https://celldex.com/publications/patients-with-chronic-spontaneous-urticaria-experience-improvement-in-quality-of-life-when-treated-with-barzolvolimab/ 2025-06-04T16:45:11+00:00 https://celldex.com/publications/barzolvolimab-demonstrates-clinical-activity-in-a-multiple-ascending-dose-trial-in-chronic-spontaneous-urticaria/ 2025-06-04T16:45:22+00:00 https://celldex.com/publications/cold-urticaria-patients-achieve-complete-response-with-1-5-mg-kg-barzolvolimab/ 2025-06-04T16:46:48+00:00 https://celldex.com/publications/multi-dosed-barzolvolimab-is-effective-in-chronic-spontaneous-urticaria/ 2025-06-04T16:48:10+00:00 https://celldex.com/publications/mast-cell-reduction-does-not-impair-human-cutaneous-wound-healing/ 2025-06-04T16:49:00+00:00 https://celldex.com/publications/effects-of-multiple-dose-treatment-with-an-anti-kit-antibody-cdx-0159-in-chronic-spontaneous-urticaria/ 2025-06-04T16:49:56+00:00 https://celldex.com/publications/the-anti-kit-antibody-cdx-0159-reduces-mast-cell-numbers-and-circulating-tryptase-and-improves-disease-control-in-patients-with-chronic-inducible-urticaria/ 2025-06-04T16:51:32+00:00 https://celldex.com/publications/cdx-0159-an-anti-kit-antibody-demonstrates-rapid-and-sustained-clinical-response-and-improved-quality-of-life-in-patients-with-chronic-inducible-urticaria/ 2025-06-04T16:52:58+00:00 https://celldex.com/publications/the-anti-kit-antibody-cdx-0159-reduces-disease-activity-and-tryptase-levels-in-patients-with-chronic-inducible-urticaria/ 2025-06-04T16:53:45+00:00 https://celldex.com/publications/cdx-0159-an-anti-kit-monoclonal-antibody-demonstrates-dose-dependent-reductions-in-plasma-tryptase-and-a-favorable-safety-profile-in-a-phase-1a-healthy-volunteer-study/ 2025-06-04T16:54:37+00:00 https://celldex.com/publications/cdx-0159-an-anti-kit-monoclonal-antibody-as-a-modulator-of-mast-cell-related-diseases/ 2025-06-04T16:55:23+00:00 https://celldex.com/publications/dual-targeting-of-mast-cells-and-tslp-with-the-bispecific-antibody-cdx-622/ 2025-06-04T16:57:33+00:00 https://celldex.com/publications/dual-inhibition-of-mast-cells-and-thymic-stromal-lymphopoietin-using-a-novel-bispecific-antibody-cdx-622/ 2025-06-04T16:57:48+00:00 https://celldex.com/publications/anti-kit-monoclonal-antibody-cdx-0159-induces-profound-and-durable-mast-cell-suppression-in-a-healthy-volunteer-study/ 2025-06-04T16:58:13+00:00 https://celldex.com/publications/barzolvolimab-induced-response-and-mast-cell-suppression-are-durable-and-linked/ 2025-06-04T16:58:26+00:00 https://celldex.com/publications/dual-targeting-of-mast-cells-and-tslp-with-a-bispecific-antibody/ 2025-06-04T16:59:22+00:00 https://celldex.com/publications/simultaneous-de-repression-of-innate-and-adaptive-immune-responses-through-dual-targeting-of-ilt4-and-pd-l1-with-bispecific-antibodies/ 2025-06-04T17:01:41+00:00 https://celldex.com/publications/anti-tumor-activity-of-a-fully-human-anti-cd27-monoclonal-antibody-in-a-transgenic-mouse-model/ 2025-06-06T13:40:45+00:00 https://celldex.com/publications/574/ 2025-06-13T11:04:08+00:00 https://celldex.com/publications/treatment-with-barzolvolimab-leads-to-sustained-improvement-in-angioedema-in-patients-with-chronic-spontaneous-urticaria-csu-results-from-52-weeks-of-treatment/ 2025-06-14T14:48:41+00:00 https://celldex.com/publications/barzolvolimab-treatment-improves-urticaria-activity-in-patients-with-chronic-spontaneous-urticaria-regardless-of-baseline-ige-levels/ 2025-09-17T09:15:12+00:00 https://celldex.com/publications/dual-targeting-of-mast-cells-and-tslp-with-the-bispecific-antibody-cdx-622-2/ 2025-11-05T23:01:46+00:00 https://celldex.com/publications/sustained-efficacy-and-safety-of-barzolvolimab-in-chronic-inducible-urticaria/ 2025-11-06T13:00:17+00:00 https://celldex.com/publications/prolonged-off-treatment-efficacy-of-barzolvolimab-in-chronic-spontaneous-urticaria/ 2026-02-27T19:45:22+00:00 https://celldex.com/publications/treatment-with-barzolvolimab-improves-urticaria-control-and-quality-of-life-in-patients-with-chronic-inducible-urticaria/ 2026-02-27T19:49:07+00:00 https://celldex.com/publications/retreatment-with-barzolvolimableads-to-rapid-improvement-in-urticaria-control-after-symptom-recurrence-in-chronic-inducible-urticaria/ 2026-03-19T12:20:01+00:00 https://celldex.com/publications/prolonged-and-enhanced-quality-of-life-in-patients-with-chronic-spontaneous-urticaria-treated-with-barzolvolimab/ 2026-03-27T14:30:35+00:00 https://celldex.com/publications/treatment-with-barzolvolimab-improves-dlqi-scores-in-all-domains-in-patients-with-chronic-inducible-urticaria/ 2026-03-27T14:30:00+00:00 https://celldex.com/publications/phase-1-study-of-cdx-622-a-bispecific-antibody-targeting-tslp-and-mast-cells-to-view-poster-via-stem-cell-factor/ 2026-06-14T09:15:59+00:00 https://celldex.com/publications/long-term-barzolvolimab-treatment-results-in-sustained-off-treatment-improvement-in-angioedema-in-patients-with-chronic-spontaneous-urticaria-refractory-to-antihistamines/ 2026-06-14T14:21:40+00:00 https://celldex.com/publications/psychometric-validation-of-the-worst-itch-numeric-rating-scale-wi-nrs-as-a-patient-reported-outcome-pro-in-cold-urticaria-data-from-a-clinical-trial-of-barzolvolimab/ 2026-06-14T14:35:42+00:00 https://celldex.com/publications/neutralization-of-soluble-stem-cell-factor-for-selective-mast-cell-targeting/ 2026-06-14T09:14:15+00:00 https://celldex.com/publications/barzolvolimab-treatment-leads-to-substantial-improvement-in-patient-reported-outcomes-and-demonstrates-corresponding-benefits-in-quality-of-life-in-chronic-inducible-urticaria/ 2026-10-12T22:21:32+00:00 https://celldex.com/publications/trial-in-progress-a-phase-3-randomized-double-blind-placebo-controlled-multicenter-parallel-group-study-of-barzolvolimab-in-participants-with-cold-urticaria-and-symptomatic-dermographism/ 2026-10-12T22:21:37+00:00 https://celldex.com/publications/barzolvolimab-treatment-leads-to-achievement-of-both-complete-response-as-well-as-no-impact-of-disease-on-quality-of-life-in-chronic-spontaneous-urticaria/ 2026-10-12T22:21:41+00:00 https://celldex.com/publications/characterization-of-kit-mediated-pigmentation-changes-observed-in-a-phase-2-trial-of-barzolvolimab-in-chronic-spontaneous-urticaria/ 2026-10-13T12:22:10+00:00